Patenting Personalized Medicine

This article discusses the patentable subject matter and timing of filing patent applications on the discoveries in the emerging field of personalized medicine.
by Leena H. Karttunen, J. Amelia Feulner, and David S. Resnick
Originally published in the Journal of Biolaw and Business, vol. 9, no. 1 (2006). Reproduced by permission. www.biolawbusiness.com

4/3/2006

Open PDF: Patenting Personalized Medicine

The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.
Boston • Chicago • Los Angeles • London • New York • Paris
Rochester • San Francisco • Shanghai • Silicon Valley • Washington • Albany
Buffalo • Long Island • Manchester • Palm Beach Gardens • Providence

Disclaimer | Nixon Peabody International | © 2010 Nixon Peabody LLP
This website contains attorney advertising. Prior results do not guarantee a similar outcome.